US · Healthcare

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Biotechnology

BridgeBio Oncology Therapeutics, Inc. (BBOT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BBOT

P/E ratio

25.00

BridgeBio Oncology Therapeutics, Inc. (BBOT) — FAQ

What is BBOT's P/E ratio?

The price-to-earnings (P/E) ratio for BridgeBio Oncology Therapeutics, Inc. (BBOT) is 25.00 (data as of 2026-05-23).

Does BridgeBio Oncology Therapeutics, Inc. pay a dividend?

Dividend yield is not available in the current snapshot for BridgeBio Oncology Therapeutics, Inc. (BBOT). Check the MyAverix Finance app for the latest dividend data.

What sector is BridgeBio Oncology Therapeutics, Inc. in?

BridgeBio Oncology Therapeutics, Inc. (BBOT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BBOT listed on?

BBOT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)